IL105551A0 - Quinazolines and pharmaceutical compositions containing them - Google Patents
Quinazolines and pharmaceutical compositions containing themInfo
- Publication number
- IL105551A0 IL105551A0 IL105551A IL10555193A IL105551A0 IL 105551 A0 IL105551 A0 IL 105551A0 IL 105551 A IL105551 A IL 105551A IL 10555193 A IL10555193 A IL 10555193A IL 105551 A0 IL105551 A0 IL 105551A0
- Authority
- IL
- Israel
- Prior art keywords
- quinazolines
- pharmaceutical compositions
- compositions containing
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88011992A | 1992-05-07 | 1992-05-07 | |
| US99116492A | 1992-12-16 | 1992-12-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL105551A0 true IL105551A0 (en) | 1993-08-18 |
Family
ID=27128564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL105551A IL105551A0 (en) | 1992-05-07 | 1993-04-29 | Quinazolines and pharmaceutical compositions containing them |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP0639184A1 (es) |
| JP (1) | JPH0813805B2 (es) |
| KR (1) | KR950701322A (es) |
| CN (1) | CN1085550A (es) |
| AU (2) | AU4220493A (es) |
| BG (1) | BG99149A (es) |
| CA (1) | CA2095194A1 (es) |
| CZ (1) | CZ272494A3 (es) |
| FI (1) | FI945199A (es) |
| HR (1) | HRP930857A2 (es) |
| HU (1) | HUT71401A (es) |
| IL (1) | IL105551A0 (es) |
| MX (1) | MX9302681A (es) |
| SI (1) | SI9300244A (es) |
| WO (1) | WO1993022292A1 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2281297A (en) * | 1993-08-27 | 1995-03-01 | Merck & Co Inc | Quinazoline compounds |
| US5434152A (en) * | 1993-11-08 | 1995-07-18 | Merck & Co., Inc. | Asymmetric synthesis of (S)-(-)-6-chloro-4- cyclopropyl-3,4-dihydro-4-[(2-pyridyl)ethynyl]-2(1H)-quinazolinone |
| HRP980143A2 (en) * | 1997-04-09 | 1999-02-28 | Soo Sung Ko | 4,4-disubstituted-3,4-dihydro-2 (1h)-quinazolinones useful as hiv reverse transcriptase inhibitors |
| US6124302A (en) * | 1997-04-09 | 2000-09-26 | Dupont Pharmaceuticals | 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors |
| CA2333643A1 (en) * | 1998-06-30 | 2000-01-06 | James D. Rodgers | Substituted quinolin-2(1h)-ones useful as hiv reverse transcriptase inhibitors |
| AU5588400A (en) | 1999-05-26 | 2000-12-18 | Du Pont Pharmaceuticals Company | 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors |
| CN1366518A (zh) * | 2000-04-25 | 2002-08-28 | 三星电子株式会社 | 作为基质金属蛋白酶抑制剂的联苯基丁酸衍生物 |
| US7119111B2 (en) | 2002-05-29 | 2006-10-10 | Amgen, Inc. | 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use |
| CA2701406C (en) * | 2007-10-05 | 2016-01-26 | Banyu Pharmaceutical Co., Ltd. | Benzoxazinone derivative |
| CN101544630B (zh) * | 2009-05-13 | 2013-03-13 | 中国科学院广州生物医药与健康研究院 | 羟基化茚地那韦的制备方法 |
| US9902703B2 (en) | 2015-07-01 | 2018-02-27 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| US11028068B2 (en) | 2017-07-25 | 2021-06-08 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL147140B (nl) * | 1968-11-26 | 1975-09-15 | Farmaceutici Italia | Werkwijze voor het bereiden van geneesmiddelen met een remmende werking op het centrale zenuwstelsel. |
| IL102764A0 (en) * | 1991-08-16 | 1993-01-31 | Merck & Co Inc | Quinazoline derivatives,and pharmaceutical compositions containing them |
-
1993
- 1993-04-28 AU AU42204/93A patent/AU4220493A/en not_active Abandoned
- 1993-04-28 HU HU9403187A patent/HUT71401A/hu unknown
- 1993-04-28 EP EP93910860A patent/EP0639184A1/en not_active Withdrawn
- 1993-04-28 WO PCT/US1993/003975 patent/WO1993022292A1/en not_active Application Discontinuation
- 1993-04-28 KR KR1019940703948A patent/KR950701322A/ko not_active Application Discontinuation
- 1993-04-28 CZ CZ942724A patent/CZ272494A3/cs unknown
- 1993-04-29 CA CA002095194A patent/CA2095194A1/en not_active Abandoned
- 1993-04-29 EP EP93201232A patent/EP0569083A1/en not_active Withdrawn
- 1993-04-29 IL IL105551A patent/IL105551A0/xx unknown
- 1993-05-05 HR HR930857A patent/HRP930857A2/hr not_active Application Discontinuation
- 1993-05-06 AU AU38413/93A patent/AU3841393A/en not_active Abandoned
- 1993-05-06 MX MX9302681A patent/MX9302681A/es unknown
- 1993-05-06 CN CN93107074A patent/CN1085550A/zh active Pending
- 1993-05-07 SI SI9300244A patent/SI9300244A/sl unknown
- 1993-05-07 JP JP5107015A patent/JPH0813805B2/ja not_active Expired - Lifetime
-
1994
- 1994-10-31 BG BG99149A patent/BG99149A/xx unknown
- 1994-11-04 FI FI945199A patent/FI945199A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP930857A2 (en) | 1995-06-30 |
| HUT71401A (en) | 1995-11-28 |
| BG99149A (en) | 1995-06-30 |
| EP0639184A1 (en) | 1995-02-22 |
| AU4220493A (en) | 1993-11-29 |
| EP0569083A1 (en) | 1993-11-10 |
| KR950701322A (ko) | 1995-03-23 |
| MX9302681A (es) | 1994-05-31 |
| FI945199A0 (fi) | 1994-11-04 |
| WO1993022292A1 (en) | 1993-11-11 |
| FI945199A (fi) | 1994-11-04 |
| JPH069578A (ja) | 1994-01-18 |
| AU3841393A (en) | 1993-11-11 |
| CZ272494A3 (en) | 1995-10-18 |
| JPH0813805B2 (ja) | 1996-02-14 |
| CN1085550A (zh) | 1994-04-20 |
| CA2095194A1 (en) | 1993-11-08 |
| SI9300244A (sl) | 1993-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL105218A0 (en) | Hexanones and pharmaceutical compositions containing them | |
| IL105223A0 (en) | Cyclohexane-ylidenes and pharmaceutical compositions containing them | |
| IL105220A0 (en) | Cyclohexanylidene compounds and pharmaceutical compositions containing them | |
| IL105806A0 (en) | Aminoquinoline derivatives and pharmaceutical compositions containing the same | |
| IL106431A0 (en) | Aminediol derivatives and pharmaceutical compositions containing the same | |
| IL111221A0 (en) | N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them | |
| IL114622A0 (en) | Heteroaryl-oxazolidinones and pharmaceutical compositions containing them | |
| IL104824A0 (en) | Heterobicyclic compounds and pharmaceutical compositions containing them | |
| NZ314376A (en) | Substituted sulphonamides and pharmaceutical compositions | |
| NZ244766A (en) | Bi-aromatic compounds and pharmaceutical compositions | |
| GB9209078D0 (en) | Pharmaceutical compositions | |
| IL111518A (en) | Isoquinolines their preparation and pharmaceutical compositions containing them | |
| IL110988A0 (en) | 4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same | |
| IL106553A0 (en) | Substituted imidazoles and pharmaceutical compositions containing them | |
| IL106098A0 (en) | Heteroarylnaphthalenes and pharmaceutical compositions containing them | |
| IL97122A0 (en) | Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them | |
| IL108073A0 (en) | Substituted 6-azaandrostenones their preparation and pharmaceutical compositions containing them | |
| HU9303304D0 (en) | Thienyl-pyrrolidinyl-carbapenem-derivatives providing antibiotic effect and pharmaceutical compositions containing it | |
| IL105551A0 (en) | Quinazolines and pharmaceutical compositions containing them | |
| IL104623A0 (en) | Biphenyl-substituted quinoline derivatives and pharmaceutical compositions containing the same | |
| IL107611A0 (en) | Steroid compounds and pharmaceutical compositions containing them | |
| GB9209874D0 (en) | Pharmaceutical compositions | |
| IL104944A0 (en) | Anti-tumor agents and pharmaceutical compositions containing the same | |
| IL111692A0 (en) | Quinoxalines and pharmaceutical compositions containing them | |
| GB9220143D0 (en) | Compounds and compositions |